Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
182.18
-1.05 (-0.57%)
At close: Oct 24, 2025, 4:00 PM EDT
181.01
-1.17 (-0.64%)
After-hours: Oct 24, 2025, 7:51 PM EDT
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.82B in the quarter ending September 30, 2025, with 13.18% growth. This brings the company's revenue in the last twelve months to $10.85B, up 13.74% year-over-year. In the year 2024, Quest Diagnostics had annual revenue of $9.87B with 6.70% growth.
Revenue (ttm)
$10.85B
Revenue Growth
+13.74%
P/S Ratio
1.88
Revenue / Employee
$193,750
Employees
56,000
Market Cap
20.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
DGX News
- 4 days ago - Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead - Seeking Alpha
- 4 days ago - Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings - Benzinga
- 5 days ago - Quest Diagnostics Incorporated (DGX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Quest Diagnostics raises annual profit and revenue forecasts on lab test demand - Reuters
- 5 days ago - Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 - PRNewsWire
- 20 days ago - Quest Diagnostics: Investing In Healthcare's Future Today - Seeking Alpha
- 26 days ago - Quest Diagnostics Incorporated (DGX) Presents at Jefferies 2025 Healthcare Services Conference Transcript - Seeking Alpha
- 4 weeks ago - Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025 - PRNewsWire